Neil Dubin, Dana R. Friedman, Paolo G. Toniolo, Bernard S. Pasternack
{"title":"Breast cancer detection centers and case-control studies of the efficacy of screening","authors":"Neil Dubin, Dana R. Friedman, Paolo G. Toniolo, Bernard S. Pasternack","doi":"10.1016/0021-9681(87)90118-4","DOIUrl":null,"url":null,"abstract":"<div><p>Case-control studies of screening efficacy have been proposed as a cost- and timeefficient alternative to randomized controlled trials. Possible source populations for such retrospective studies of breast cancer screening are considered, including women from (i) pre-existing randomized trials, (ii) non-experimental population-based studies and (iii) detection centers. On practical grounds women attending detection centers are seen to comprise the most readily accessible source of adequate numbers of cases and controls. Potential biases are addressed, involving incomplete case ascertainment, self-selection, and different screening recommendations. Data from the Guttman Breast Diagnostic Institute are used for illustration.</p></div>","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"40 11","pages":"Pages 1041-1050"},"PeriodicalIF":0.0000,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0021-9681(87)90118-4","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of chronic diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0021968187901184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14
Abstract
Case-control studies of screening efficacy have been proposed as a cost- and timeefficient alternative to randomized controlled trials. Possible source populations for such retrospective studies of breast cancer screening are considered, including women from (i) pre-existing randomized trials, (ii) non-experimental population-based studies and (iii) detection centers. On practical grounds women attending detection centers are seen to comprise the most readily accessible source of adequate numbers of cases and controls. Potential biases are addressed, involving incomplete case ascertainment, self-selection, and different screening recommendations. Data from the Guttman Breast Diagnostic Institute are used for illustration.